172 related articles for article (PubMed ID: 20037964)
1. Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge.
Deshpande MS; Jirjis FF; Tubbs AL; Jayappa H; Sweeney D; Spencer SJ; Lakshmanan N; Wasmoen TL
Vet Ther; 2009; 10(3):103-12. PubMed ID: 20037964
[TBL] [Abstract][Full Text] [Related]
2. Experimental reproduction of canine influenza virus H3N8 infection in young puppies.
Deshpande M; Abdelmagid O; Tubbs A; Jayappa H; Wasmoen T
Vet Ther; 2009; 10(1-2):29-39. PubMed ID: 19742446
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus.
Lee C; Jung K; Oh J; Oh T; Han S; Hwang J; Yeom M; Son D; Kim J; Park B; Moon H; Song D; Kang B
Vet Microbiol; 2010 Jul; 143(2-4):184-8. PubMed ID: 20034748
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs.
Karaca K; Dubovi EJ; Siger L; Robles A; Audonnet JC; Jiansheng Y; Nordgren R; Minke JM
Am J Vet Res; 2007 Feb; 68(2):208-12. PubMed ID: 17269888
[TBL] [Abstract][Full Text] [Related]
6. Transmission of canine influenza virus (H3N8) among susceptible dogs.
Jirjis FF; Deshpande MS; Tubbs AL; Jayappa H; Lakshmanan N; Wasmoen TL
Vet Microbiol; 2010 Aug; 144(3-4):303-9. PubMed ID: 20347235
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
8. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
9. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
[TBL] [Abstract][Full Text] [Related]
10. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of and exposure factors for seropositivity to H3N8 canine influenza virus in dogs with influenza-like illness in the United States.
Anderson TC; Crawford PC; Dubovi EJ; Gibbs EP; Hernandez JA
J Am Vet Med Assoc; 2013 Jan; 242(2):209-16. PubMed ID: 23276098
[TBL] [Abstract][Full Text] [Related]
12. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
[TBL] [Abstract][Full Text] [Related]
13. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
14. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells.
Quintana AM; Hussey SB; Burr EC; Pecoraro HL; Annis KM; Rao S; Landolt GA
Am J Vet Res; 2011 Aug; 72(8):1071-8. PubMed ID: 21801065
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
Lee JH; Gramer MR; Joo HS
Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
[TBL] [Abstract][Full Text] [Related]
17. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
Wesley RD; Lager KM
Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
19. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
20. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
